Marianne P. Allen

Array ( [id] => 8571527 [patent_doc_number] => 08338171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Baboon homolog of human CD147' [patent_app_type] => utility [patent_app_number] => 12/855214 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 5243 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12855214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10869812 [patent_doc_number] => 08895005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Therapeutic agent' [patent_app_type] => utility [patent_app_number] => 12/849536 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 16 [patent_no_of_words] => 20681 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12849536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8779613 [patent_doc_number] => 20130101588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/848774 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31740 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12848774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602603 [patent_doc_number] => 20100322998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'SKIN ULCER PREVENTIVE CURATIVE AGENT CONTAINING HUMAN RECOMBINANT HGF' [patent_app_type] => utility [patent_app_number] => 12/842349 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10747 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322998.pdf [firstpage_image] =>[orig_patent_app_number] => 12842349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745386 [patent_doc_number] => 20130085103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'NOVEL SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/701066 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10089 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134359 [patent_doc_number] => 20110008281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'CARDIOPROTECTIVE ROLE OF HEPATIC CELLS AND HEPATOCYTE SECRETORY FACTORS IN MYOCARDIAL ISCHEMIA' [patent_app_type] => utility [patent_app_number] => 12/833534 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 23527 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008281.pdf [firstpage_image] =>[orig_patent_app_number] => 12833534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581691 [patent_doc_number] => 08771692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Methods for treatment of muscular dystrophy' [patent_app_type] => utility [patent_app_number] => 13/380489 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 14846 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13380489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054593 [patent_doc_number] => 20110110953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Compound and method for treatment of chronic transplant rejection' [patent_app_type] => utility [patent_app_number] => 12/803117 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12822 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110953.pdf [firstpage_image] =>[orig_patent_app_number] => 12803117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549279 [patent_doc_number] => 08324160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Chimeric polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/817084 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 76 [patent_no_of_words] => 24685 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12817084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6583503 [patent_doc_number] => 20100291212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING FGF18 AND IL-1 ANTAGONIST AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 12/784377 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7752 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291212.pdf [firstpage_image] =>[orig_patent_app_number] => 12784377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266403 [patent_doc_number] => 20100298220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'FIBROBLAST GROWTH FACTOR MUTANTS HAVING IMPROVED FUNCTIONAL HALF-LIFE AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/783005 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 33111 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298220.pdf [firstpage_image] =>[orig_patent_app_number] => 12783005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500117 [patent_doc_number] => 20100215655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'ANGIOGENESIS-INHIBITING CHIMERIC PROTEINS AND THE USE' [patent_app_type] => utility [patent_app_number] => 12/773315 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5028 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215655.pdf [firstpage_image] =>[orig_patent_app_number] => 12773315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8187158 [patent_doc_number] => 20120116059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Treatment For M\nTreatment For Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 13/318149 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10049 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116059.pdf [firstpage_image] =>[orig_patent_app_number] => 13318149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358592 [patent_doc_number] => 20120213744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING STEM CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/266428 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 33477 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6511642 [patent_doc_number] => 20100210826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'HGF BETA CHAIN VARIANTS' [patent_app_type] => utility [patent_app_number] => 12/768557 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21247 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210826.pdf [firstpage_image] =>[orig_patent_app_number] => 12768557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270786 [patent_doc_number] => 20100254993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN IL-4' [patent_app_type] => utility [patent_app_number] => 12/760891 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8308 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254993.pdf [firstpage_image] =>[orig_patent_app_number] => 12760891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6379684 [patent_doc_number] => 20100316596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH CYTOKINE SIGNALING' [patent_app_type] => utility [patent_app_number] => 12/759496 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 43825 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316596.pdf [firstpage_image] =>[orig_patent_app_number] => 12759496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262249 [patent_doc_number] => 20100297074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Wound healing compositions, systems, and methods' [patent_app_type] => utility [patent_app_number] => 12/798729 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18049 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297074.pdf [firstpage_image] =>[orig_patent_app_number] => 12798729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13168017 [patent_doc_number] => 10100112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Therapeutic agents for the treatment of diseases associated with undesired cell proliferation [patent_app_type] => utility [patent_app_number] => 13/138804 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20619 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13138804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777390 [patent_doc_number] => 08852590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Compositions and methods for treating cancer' [patent_app_type] => utility [patent_app_number] => 13/264060 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 23063 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264060 [rel_patent_id] =>[rel_patent_doc_number] =>)